Cas:113975-75-0 Methyl (2E)-(hydroxyimino)(1H-indol-3-yl)acetate manufacturer & supplier

Chemical Name:Methyl (2E)-(hydroxyimino)(1H-indol-3-yl)acetate

CAS.NO:113975-75-0

Synonyms:methyl imidazo<1,5-a>pyridine-8-carboxylate;methyl indol-3-ylglyoxylate oxime;1H-Indole-3-acetic acid, α-(hydroxyimino)-, methyl ester, (αE)-;Methyl (2E)-(hydroxyimino)(1H-indol-3-yl)acetate

Molecular Formula:C₁₁H₁₀N₂O₃

Molecular Weight:218.209

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:445.9±37.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.622

PSA:74.68000

Exact Mass:218.069138

LogP:1.65

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like methyl imidazo&lt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl (2E)-(hydroxyimino)(1H-indol-3-yl)acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl indol-3-ylglyoxylate oxime Use and application,1H-Indole-3-acetic acid, α-(hydroxyimino)-, methyl ester, (αE)- technical grade,usp/ep/jp grade.

Related News: The South Korean government is banning entry to all foreign nationals who visited China’s Hubei province in the past 14 days. Methyl (2E)-(hydroxyimino)(1H-indol-3-yl)acetate manufacturer Process: The importance of safety is obvious. The research and development of specialty drug substances (especially high-barrier generic drug substance drugs) usually need to avoid the original process patents, and some chemicals are developed because of the complex structure or the harsh synthetic conditions The synthetic route is more difficult, so the importance of process design capabilities of API companies is becoming more important. Methyl (2E)-(hydroxyimino)(1H-indol-3-yl)acetate supplier The complete chemical and pharmaceutical industry chain consists of basic chemical raw materials, pharmaceutical intermediates, chemical raw materials and chemical preparations. Methyl (2E)-(hydroxyimino)(1H-indol-3-yl)acetate vendor Lilly has pledged to address the problems, and said none of them affected drugs in the market. The FDA, which has taken no public action, did not respond to requests for comment. Methyl (2E)-(hydroxyimino)(1H-indol-3-yl)acetate factory The complete chemical and pharmaceutical industry chain consists of basic chemical raw materials, pharmaceutical intermediates, chemical raw materials and chemical preparations.